Steinmetz, Carolin
Krause, Laura
Sulejmanovic, Samra
Kaumkötter, Sabrina
Mengden, Thomas
Grefe, Clemens
Knoglinger, Ernst
Reiss, Nils
Brixius, Klara
Bjarnason-Wehrens, Birna
Schmidt, Thomas
von Haehling, Stephan
Sadlonova, Monika
von Arnim, Christine A. F.
Heinemann, Stephanie
Funding for this research was provided by:
Herzzentrum Göttingen
Article History
Received: 20 October 2023
Accepted: 10 January 2024
First Online: 24 January 2024
Declarations
:
: The cohort study was approved by the local ethics committee of the University Medical Center Göttingen (approval reference number: 23/11/22; November 18, 2022) and conforms to the Declaration of Helsinki. All participants signed informed consent forms.
: Not applicable.
: CAFvA received honoraria from serving on the scientific advisory board of Biogen, Roche, Novo Nordisk and Dr. Willmar Schwabe GmbH & Co. KG and has received funding for travel as well as speaker honoraria from Biogen, Roche diagnostics AG, Medical Tribune Verlagsgesellschaft mbH, Landesvereinigung für Gesundheit und Akademie für Sozialmedizin Niedersachsen e. V. and Dr. Willmar Schwabe GmbH & Co. KG. CAFvA has received research support from Roche diagnostics AG and research funding from the Innovationsfond (Fund of the Federal Joint Committee, Gemeinsamer Bundesausschuss, G-BA Grants No. VF1_2016–201; 01NVF21010; 01VSF21019). The other authors declare that they have no competing interests.